Main competitors
P/E (N) Price to Book (N) PEG (N) EV / Sales (N) EV / EBITDA (N) EV / EBIT (N) Dividend Yield (N) Capi.($)
16.23x - -0.07x4.87x16.91x14.51x-.--% 1.76B
32.43x6.17x0.76x8.43x25.48x26.22x0.06% 55.01B
15.98x3.08x-1.86x4.88x10.61x12.31x1.86% 43.37B
-17.36x1.08x2.67x3.95x-6.9x-5.59x-.--% 22.27B
-35.24x49.9x0.6x11.68x-33.72x-36.9x-.--% 20.42B
21.35x2.1x1.49x4.19x10.89x13.09x-.--% 17.27B
21.02x2.39x-0.94x4.23x13.99x15.71x-.--% 15.02B
16.69x4.72x1.23x4.81x11.27x12.41x-.--% 13.25B
-410.69x16.85x8.33x27.93x-3113.74x-305.69x-.--% 11.71B
-13.05x153.36x0.63x3397.02x-15.86x-12.91x-.--% 11.46B
-71.3x24.98x1.52x7.15x-67.43x-52.52x-.--% 11.23B
40.44x9.15x0.57x14.25x41.04x38.39x0.18% 11.03B
1142.52x7.88x-10.8x13.37x75.87x184.7x-.--% 11B
-23.15x23.77x-0x20.98x-26.92x-21.78x-.--% 10.3B
-11.06x-45.82x9.53x83.48x-12.45x-12.12x-.--% 9.7B
-8.14x - -0.07x - - - - 7.25B
-15.73x6.08x13.56x547.36x-13.34x-13.28x-.--% 7.18B
10.41x4.98x0.03x6.5x10.51x11.1x-.--% 7.17B
26.76x4.37x-2.14x6.04x23.49x26.8x - 7.1B
113.21x2.29x-1.99x4.55x22.59x49.31x0.13% 7B
Average 42.57x 15.41x 1.15x 219.77x -159.35x -2.96x 0.12% 15.02B
Weighted average by Cap. 33.62x 13.72x 0.77x 156.67x -118.00x 0.23x 0.3%
Bio Therapeutic Drugs